曼联 MANU 深 沪
等待开盘 08-20 09:30:00 美东时间
23.93
+0.420
+1.79%
华盛通- 最 高24.01
- 今 开23.70
- 成交量 32.16万股
- 最 低 23.655
- 昨 收 23.51
- 总市值 41.26亿
- 52周最高 24.45
- 市盈率 静 --
- 换手率 0.19%
- 52周最低 14.585
- 委 比 20.00%
- 总股本 1.72亿
- 历史最高 27.34
- 量 比 0.68
- 振 幅 1.51%
- 历史最低 10.41
- 每 手 1
- 风险率 2.58%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多英超新赛季周末揭幕，曼联旧帅为何在此时抵沪？
（来源：上观新闻） 新华社照片，伦敦，2026年4月12日 4月11日，阿森纳队球员在比赛前相互鼓励。 当地时间4月11日，在20...
08-19 12:18
Chelsea F.C. shareholders Walter and Boehly selling stake—Financial Times
Billionaire investor and the former owner of the LA Lakers, Mark Walter, along with co-investor Todd Boehly, are reportedly in talks to sell their stake in Chelsea Football Club to majority owner Clea...
08-18 01:25
Pilgrim's Agrees to Acquisition of Walkers Deli & Sausage Company
Pilgrim's Europe has agreed to acquire Walkers Deli & Sausage Company from Samworth Brothers, subject to CMA approval and employee consultation. Walkers, a UK premium pork producer with a history dating back to 1824, operates four facilities and employs 1,150 people. The acquisition strengthens Pilgrim's position in the UK food industry and expands its presence in premium pork categories. Fabio Sandri, CEO of Pilgrim’s, highlighted the deal as a ...
08-17 13:15
Elon Musk Joked About Buying Manchester United — Now Jeff Bezos Is Buying Into Its Biggest Rival
While sports team ownership has landed multiple billionaires around the world, Elon Musk and Mark Zuckerberg are two of the world’s richest people and have yet to add this investment to their portfolio. Two of their rivals may be doing just that. Jeff Bezos, Eduardo Saverin Liverpool Stake Amazon.co...
08-11 00:56
美国富豪缘何纷纷青睐收购英国足球俱乐部
核心要点 近些年，美资控股英超俱乐部的数量稳步上涨； 芬威体育集团计划出售利物浦少数股权，有望斩获高额投资回报； 深度解析足球为何在美国投资者眼中成为极具...
07-29 16:59
Joby Aviation rises after finalizing Virgin Atlantic deal
Joby Aviation (JOBY) shares rose nearly 7% in premarket trading on Wednesday after the electric air taxi developer finalized its partnership with Virgin Atlantic, converting an agreement announced in ...
07-22 18:07
Greenwich LifeSciences Announces Approval to Expand FLAMINGO-01 into the United Kingdom
Greenwich LifeSciences announced regulatory approval to expand its Phase III FLAMINGO-01 clinical trial into the UK, potentially adding 5-10 new sites. The trial evaluates GLSI-100, an immunotherapy to prevent breast cancer recurrences. Collaborating with The Royal Marsden, a leading cancer research institute, the company aims to offer participation to UK patients. FLAMINGO-01 has shown a 70-80% reduction in recurrence rates in the non-HLA-A*02 a...
07-22 10:00
